F2RL1 and neoplasm: PAR-2 activation has been shown to stabilize β-catenin by inhibiting its proteasomal degradation, thereby sustaining oncogenic transcriptional programs that promote tumor growth, epithelial–mesenchymal transition (EMT), and stemness.